Banner

Impact of prior authorization for cataract surgery

Podcast

Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients.

Michael Rivers, MD, director of Ophthalmology at Modernizing Medicine, discusses Aetna's new policy requiring prior authorization for cataract surgery, its impact on ophthalmologists and patients, as well as potential solutions — and additional issues — that may arise in the future as a result.

See more ASCRS coverage

Listen to more podcasts

Related Videos
Related Content

Alcon reveals final data from Vivity Registry Study which demonstrates sustained high patient satisfaction and reduced spectacle dependence

September 13th 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

WIO 2023: The latest thinking on diagnosing and treating dry eye disease and keratitis

August 26th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

WIO 2023: Needed: Clinically meaningful dry eye outcomes and metrics ocular surface staining very useful

August 25th 2023

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Alcon reveals final data from Vivity Registry Study which demonstrates sustained high patient satisfaction and reduced spectacle dependence

September 13th 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

WIO 2023: The latest thinking on diagnosing and treating dry eye disease and keratitis

August 26th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

WIO 2023: Needed: Clinically meaningful dry eye outcomes and metrics ocular surface staining very useful

August 25th 2023

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Alcon reveals final data from Vivity Registry Study which demonstrates sustained high patient satisfaction and reduced spectacle dependence

September 13th 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

WIO 2023: The latest thinking on diagnosing and treating dry eye disease and keratitis

August 26th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

WIO 2023: Needed: Clinically meaningful dry eye outcomes and metrics ocular surface staining very useful

August 25th 2023

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023
© 2023 MJH Life Sciences

All rights reserved.